Stock Scorecard
Stock Summary for Intuitive Surgical Inc (ISRG) - $504.15 as of 2/2/2026 8:17:02 AM EST
Total Score
15 out of 30
Safety Score
65 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for ISRG
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ISRG
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ISRG
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ISRG
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ISRG (65 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 2 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Financial Details for ISRG
Company Overview |
|
|---|---|
| Ticker | ISRG |
| Company Name | Intuitive Surgical Inc |
| Country | USA |
| Description | Intuitive Surgical, Inc. is a premier American medical technology firm, recognized for pioneering robotic-assisted surgical systems, notably the da Vinci Surgical System. The company is dedicated to enhancing patient outcomes through the innovation of minimally invasive surgical technologies, complemented by a diverse range of instruments and extensive training initiatives for healthcare practitioners. Boasting a strong pipeline of technological advancements, Intuitive Surgical is strategically positioned to leverage growth opportunities in the rapidly evolving robotic surgery sector, promoting improved surgical precision and expedited patient recovery. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 4/21/2026 |
Stock Price History |
|
| Last Day Price | 504.15 |
| Price 4 Years Ago | 265.35 |
| Last Day Price Updated | 2/2/2026 8:17:02 AM EST |
| Last Day Volume | 1,696,619 |
| Average Daily Volume | 1,833,510 |
| 52-Week High | 609.08 |
| 52-Week Low | 425.00 |
| Last Price to 52 Week Low | 18.62% |
Valuation Measures |
|
| Trailing PE | 64.84 |
| Industry PE | 2,171.51 |
| Sector PE | 188.49 |
| 5-Year Average PE | 64.52 |
| Free Cash Flow Ratio | 63.66 |
| Industry Free Cash Flow Ratio | 34.10 |
| Sector Free Cash Flow Ratio | 30.14 |
| Current Ratio Most Recent Quarter | 4.73 |
| Total Cash Per Share | 7.92 |
| Book Value Per Share Most Recent Quarter | 50.55 |
| Price to Book Ratio | 10.03 |
| Industry Price to Book Ratio | 3.86 |
| Sector Price to Book Ratio | 57.14 |
| Price to Sales Ratio Twelve Trailing Months | 18.18 |
| Industry Price to Sales Ratio Twelve Trailing Months | 162.91 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.56 |
| Analyst Buy Ratings | 14 |
| Analyst Strong Buy Ratings | 7 |
Share Statistics |
|
| Total Shares Outstanding | 354,496,000 |
| Market Capitalization | 178,719,158,400 |
| Institutional Ownership | 88.88% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.19% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 17.10% |
| Annual Earnings Growth | 22.97% |
| Reported EPS 12 Trailing Months | 7.87 |
| Reported EPS Past Year | 8.93 |
| Reported EPS Prior Year | 7.33 |
| Net Income Twelve Trailing Months | 2,856,000,000 |
| Net Income Past Year | 2,856,000,000 |
| Net Income Prior Year | 2,322,600,000 |
| Quarterly Revenue Growth YOY | 18.80% |
| 5-Year Revenue Growth | 18.22% |
| Operating Margin Twelve Trailing Months | 30.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,806,600,000 |
| Total Cash Past Year | 2,027,400,000 |
| Total Cash Prior Year | 2,027,400,000 |
| Net Cash Position Most Recent Quarter | 2,806,600,000 |
| Net Cash Position Past Year | 2,027,400,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 16,433,700,000 |
| Total Stockholder Equity Prior Year | 16,433,700,000 |
| Total Stockholder Equity Most Recent Quarter | 16,929,700,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 2,271,300,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 6.41 |
| Free Cash Flow Past Year | 1,303,800,000 |
| Free Cash Flow Prior Year | 749,600,000 |
Options |
|
| Put/Call Ratio | 0.42 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -11.05 |
| MACD Signal | -7.26 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 1.67 |
| RSI | 37.87 |
| 50-Day SMA | 517.18 |
| 150-Day SMA | 433.38 |
| 200-Day SMA | 383.65 |
System |
|
| Modified | 1/31/2026 1:31:42 AM EST |